Article

Hepatitis C Drug Breakthrough Highlights Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/hepatitis-c-drug-breakthrough-warning-highlights-s" target="_blank">View the story "Hepatitis C Drug Breakthrough Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Related Content
Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists

Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Schizophrenia disorder and psychiatric disease or mental health as a psychiatry and psychology concept for human abnormal personality behavior and mood illness
October 14th 2024

Improving Schizophrenia Outcomes: The Role of Long-Acting Injectables and Medication Adherence

Brooke Kempf, PMHNP
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Early Parkinson Disease and the Potential Therapeutic Role of Lixisenatide
October 11th 2024

Early Parkinson Disease and the Potential Therapeutic Role of Lixisenatide

Kamila Dymala, PharmD, MBA, BCMTMS, PACS
Exterior view of the headquarters of US Food and Drug Administration (FDA)
October 11th 2024

Facing Industry Disruptions, FDA Grants Temporary Exemption From DSCSA Requirements For Trading Partners

Luke Halpern, Assistant Editor